Salarius Pharmaceuticals IncNASDAQ:SLRX
- LAST PRICE3.1900
- TODAY'S CHANGE (%)-0.3100 (-8.8571%)
- Bid / Lots3.1000/ 55
- Ask / Lots3.1400/ 2
- Open / Previous Close3.2000 / 3.5000
- Day Range
- 52 Week Range
- Volume1,275,784
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | SLRX |
|---|---|---|
| 09:32 ET | 20247 | 3.015 |
| 09:34 ET | 3864 | 3.04 |
| 09:36 ET | 7178 | 3.0055 |
| 09:38 ET | 36020 | 2.8901 |
| 09:39 ET | 10363 | 2.94 |
| 09:41 ET | 8108 | 2.96 |
| 09:43 ET | 12228 | 2.98 |
| 09:45 ET | 26810 | 3.03 |
| 09:48 ET | 22423 | 3.045 |
| 09:50 ET | 1766 | 3.0686 |
| 09:52 ET | 664 | 3.0048 |
| 09:54 ET | 3386 | 3.03 |
| 09:56 ET | 7554 | 2.98 |
| 09:57 ET | 636 | 2.985 |
| 09:59 ET | 66296 | 2.8801 |
| 10:01 ET | 8502 | 2.8901 |
| 10:03 ET | 12678 | 2.8423 |
| 10:06 ET | 21143 | 2.88 |
| 10:08 ET | 5113 | 2.87 |
| 10:10 ET | 1280 | 2.8755 |
| 10:12 ET | 1245 | 2.885 |
| 10:14 ET | 3797 | 2.88 |
| 10:15 ET | 16305 | 2.85 |
| 10:17 ET | 6750 | 2.8699 |
| 10:19 ET | 3666 | 2.8793 |
| 10:21 ET | 1847 | 2.89 |
| 10:24 ET | 11541 | 2.96 |
| 10:26 ET | 24767 | 3.0199 |
| 10:28 ET | 13332 | 2.9423 |
| 10:30 ET | 7734 | 2.821 |
| 10:32 ET | 3290 | 2.8603 |
| 10:33 ET | 1052 | 2.88 |
| 10:35 ET | 856 | 2.91 |
| 10:37 ET | 715 | 2.8701 |
| 10:39 ET | 3917 | 2.93 |
| 10:42 ET | 4933 | 2.945 |
| 10:44 ET | 3342 | 2.86 |
| 10:46 ET | 1000 | 2.9299 |
| 10:50 ET | 2360 | 2.8453 |
| 10:51 ET | 5501 | 2.85 |
| 10:53 ET | 1002 | 2.8599 |
| 10:55 ET | 4375 | 2.8213 |
| 10:57 ET | 18098 | 2.91 |
| 11:00 ET | 30104 | 2.94 |
| 11:02 ET | 9475 | 3.02 |
| 11:04 ET | 10062 | 2.9703 |
| 11:06 ET | 2729 | 2.9758 |
| 11:08 ET | 1227 | 2.99 |
| 11:11 ET | 100 | 2.9797 |
| 11:15 ET | 500 | 2.9502 |
| 11:18 ET | 300 | 2.955 |
| 11:20 ET | 900 | 2.97 |
| 11:22 ET | 15854 | 3.0001 |
| 11:24 ET | 5269 | 3 |
| 11:26 ET | 1000 | 2.9882 |
| 11:29 ET | 1728 | 2.9744 |
| 11:31 ET | 2825 | 2.97 |
| 11:33 ET | 1950 | 2.96 |
| 11:36 ET | 1613 | 2.96 |
| 11:38 ET | 2013 | 2.9301 |
| 11:40 ET | 398 | 2.9336 |
| 11:42 ET | 1375 | 2.93 |
| 11:44 ET | 2072 | 2.95 |
| 11:45 ET | 600 | 2.96 |
| 11:47 ET | 1800 | 2.98 |
| 11:49 ET | 100 | 2.96 |
| 11:51 ET | 963 | 2.96 |
| 11:54 ET | 1499 | 3.01 |
| 11:56 ET | 1173 | 3.0073 |
| 12:00 ET | 1493 | 2.96 |
| 12:02 ET | 450 | 2.9601 |
| 12:03 ET | 195 | 2.9637 |
| 12:05 ET | 2699 | 3.0299 |
| 12:07 ET | 2288 | 3 |
| 12:09 ET | 100 | 3 |
| 12:12 ET | 3998 | 3 |
| 12:14 ET | 8512 | 3.01 |
| 12:16 ET | 12363 | 3.09 |
| 12:18 ET | 49394 | 3.2571 |
| 12:20 ET | 30935 | 3.4 |
| 12:21 ET | 5436 | 3.345 |
| 12:23 ET | 3759 | 3.37 |
| 12:25 ET | 36759 | 3.2 |
| 12:27 ET | 13117 | 3.19 |
| 12:30 ET | 1549 | 3.149 |
| 12:32 ET | 1331 | 3.195 |
| 12:34 ET | 12063 | 3.21 |
| 12:36 ET | 10812 | 3.19 |
| 12:38 ET | 2447 | 3.1385 |
| 12:39 ET | 702 | 3.165 |
| 12:41 ET | 1900 | 3.15 |
| 12:43 ET | 3282 | 3.16 |
| 12:45 ET | 300 | 3.125 |
| 12:48 ET | 369 | 3.11 |
| 12:50 ET | 700 | 3.145 |
| 12:52 ET | 3297 | 3.1001 |
| 12:54 ET | 918 | 3.1 |
| 12:56 ET | 1032 | 3.1 |
| 12:57 ET | 129 | 3.07 |
| 01:01 ET | 150 | 3.115 |
| 01:03 ET | 500 | 3.1229 |
| 01:06 ET | 2589 | 3.14 |
| 01:08 ET | 400 | 3.1499 |
| 01:10 ET | 1100 | 3.16 |
| 01:12 ET | 1187 | 3.1101 |
| 01:14 ET | 1400 | 3.15 |
| 01:15 ET | 11246 | 3.196 |
| 01:17 ET | 3184 | 3.25 |
| 01:19 ET | 300 | 3.27 |
| 01:21 ET | 1100 | 3.2101 |
| 01:24 ET | 150 | 3.245 |
| 01:26 ET | 9271 | 3.19 |
| 01:28 ET | 15026 | 3.1799 |
| 01:32 ET | 40136 | 3.02 |
| 01:33 ET | 6421 | 2.92 |
| 01:35 ET | 1807 | 2.9607 |
| 01:37 ET | 494 | 2.9299 |
| 01:39 ET | 720 | 2.96 |
| 01:42 ET | 14004 | 2.8957 |
| 01:44 ET | 4919 | 2.935 |
| 01:46 ET | 3041 | 2.92 |
| 01:48 ET | 1000 | 2.9214 |
| 01:50 ET | 708 | 2.9258 |
| 01:51 ET | 1200 | 2.91 |
| 01:53 ET | 3015 | 2.91 |
| 01:57 ET | 8546 | 3.02 |
| 02:00 ET | 600 | 2.98 |
| 02:02 ET | 2713 | 2.945 |
| 02:04 ET | 1250 | 3.0099 |
| 02:09 ET | 300 | 2.97 |
| 02:11 ET | 540 | 2.9372 |
| 02:13 ET | 15812 | 3.01 |
| 02:15 ET | 4700 | 3 |
| 02:18 ET | 1300 | 2.99 |
| 02:20 ET | 100 | 2.9964 |
| 02:22 ET | 940 | 2.97 |
| 02:27 ET | 200 | 2.97 |
| 02:29 ET | 573 | 3.04 |
| 02:33 ET | 250 | 2.9509 |
| 02:36 ET | 100 | 2.995 |
| 02:38 ET | 1863 | 2.92 |
| 02:40 ET | 2099 | 2.96 |
| 02:45 ET | 11797 | 2.9837 |
| 02:47 ET | 3718 | 3.0597 |
| 02:49 ET | 3013 | 3.0201 |
| 02:51 ET | 3999 | 2.99 |
| 02:54 ET | 253 | 2.9883 |
| 02:56 ET | 190 | 2.99 |
| 02:58 ET | 4086 | 3 |
| 03:02 ET | 2249 | 2.95 |
| 03:12 ET | 500 | 2.975 |
| 03:16 ET | 200 | 2.93 |
| 03:18 ET | 900 | 2.97 |
| 03:21 ET | 246 | 2.98 |
| 03:23 ET | 3053 | 2.99 |
| 03:25 ET | 517 | 2.99 |
| 03:30 ET | 116 | 2.9701 |
| 03:34 ET | 800 | 2.9704 |
| 03:38 ET | 1657 | 3.0012 |
| 03:39 ET | 3598 | 3.06 |
| 03:41 ET | 12481 | 3.13 |
| 03:43 ET | 7046 | 3.1652 |
| 03:45 ET | 5769 | 3.1101 |
| 03:50 ET | 12375 | 3.1205 |
| 03:52 ET | 950 | 3.13 |
| 03:54 ET | 8998 | 3.14 |
| 03:56 ET | 4276 | 3.17 |
| 03:57 ET | 29410 | 3.19 |
| 03:59 ET | 10331 | 3.19 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Salarius Pharmaceuticals Inc | 2.1M | -0.1x | --- |
CTT Pharmaceutical Holdings Inc | 2.1M | -0.5x | --- |
VG Life Sciences Inc | 2.1M | 0.0x | --- |
180 Life Sciences Corp | 2.2M | -0.1x | --- |
Scinai Immunotherapeutics Ltd | 2.2M | 0.0x | --- |
Phio Pharmaceuticals Corp | 2.0M | -0.1x | --- |
Company Information
Salarius Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is developing treatments for parties with cancers in need of new treatment options. Its product portfolio includes seclidemstat, an oral novel small molecule inhibitor of the LSD1 enzyme and the Company's lead candidate, which is being studied as a potential treatment for pediatric cancers, sarcomas, and other cancers with limited treatment options, and SP-3164, an oral small molecule protein degrader being developed for the treatment of Non-Hodgkins Lymphoma. SP-3164 is a small molecule protein degrader, and seclidemstat (SP-2577) is a small molecule inhibitor. SP-3164 is a next-generation cereblon-binding molecular glue (MG). SP-2577 is a small-molecule LSD1 inhibitor with a novel scaffold. The molecule was discovered using structure-based computational screening coupled with chemical screening and further optimization with structure-activity relationship studies.
Contact Information
- Headquarters
- 2450 Holcombe Blvd Ste J-608HOUSTON, TX, United States 77021-2041
- Phone
- 617-874-1821
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- William McVicar
- President, Chief Executive Officer, Director
- David Arthur
- Chief Financial Officer, Executive Vice President - Finance
- Mark Rosenblum
- Independent Director
- Tess Burleson
- Independent Director
- Arnold Hanish
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.1M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 597.1K |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.85 |
EPS | $-21.71 |
Book Value | $10.74 |
P/E Ratio | -0.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
